3-O-methylglucose (3-OMeG) is a nonmetabolizable glucose analog and is, therefore, suitable for transport studies. 3-OMeG and glucose compete for entry into normal and Rous sarcoma virus (RSV)-transformed chick-embryo fibroblasts. Therefore, 3-OMeG can be used to study the transport of glucose in these cells. Chickembryo fibroblasts infected and transformed by RSV take up 3-OMeG at a faster rate than uninfected cells when both cell types are growing at the same rate. The rate of efflux of 3-OMeG also increases after transformation. When the uptake and the efflux reach a steady state, the intracellular concentration of 3-OMeG is equal to the concentration in the medium. This finding indicates that glucose is transported across the plasma membrane by facilitated diffusion. The V. of the transport system for 3-OMeG increases after transformation, while the affinity or Km of the system remains unchanged. We conclude that viral transformation causes a change in the plasma membrane of the infected cells by increasing either the number of molecules or the mobility of the glucose carrier.
cilitated diffusion. The V. of the transport system for 3-OMeG increases after transformation, while the affinity or Km of the system remains unchanged. We conclude that viral transformation causes a change in the plasma membrane of the infected cells by increasing either the number of molecules or the mobility of the glucose carrier.
Avian or mammalian cells can be transformed in vitro by RNA tumor viruses. The transformed cells are characterized by altered morphology, random orientation, and release from density-dependent inhibition (1) . One of the earliest manifestations of the transformation is an increased rate of glucose accumulation inside the cells (2, 3) .
Temperature-sensitive mutants of Rous sarcoma virus (RSV) have been isolated (3) (4) (5) . These mutants transform chick-embryo fibroblasts (CK) only at low temperature (36°), while they can infect and replicate at both high (410) and low temperatures. Thus, it is possible to distinguish between early and late events of the infection-transformation process because transformation can be initiated synchronously in the whole cell population simply by shifting the temperature of cells infected at 41°-36°.
We studied (2) the rate of 2-deoxy-D-glucose (2-dOG) accumulation inside chick-embryo fibroblasts infected with one of the mutants described above, T5 (4). 2-deoxy-D-glucose is a glucose analog that is taken up and phosphorylated by the cell, but is not further metabolized (6, 7). 2-dOG and glucose compete with one another in normal and RSV-transformed chick-embryo fibroblasts, CK(RSV) (Venuta, unpublished).
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Thus, 2-dOG is useful for studying the rate of entry of glucose from the medium into the intracellular pool of -glucose-6-phosphate (G-6-P). It was shown that there is an increase in the rate of 2-dOG accumulation inside the cells immediately after the cells infected with T5 are shifted to the permissive temperature and that this change is not due to a difference in growth rate between normal and transformed cells (2) . It was not possible to conclude whether transport or phosphorylation was responsible for the increased rate of glucose accumulation in the transformed cells.
To distinguish between these two possibilities, we examined the uptake of 3-O-methylglucose (3-OMeG) in normal and RSV-transformed CK(RSV) chick cells. 3-OMeG is a glucose analog that can be transported into the cells, but that cannot be phosphorylated by the hexokinase (8) (9) (10) . We show that 3-OMeG and glucose use the same carrier system, that the rate of transport of 3-OMeG into the cell, as well as its rate of exit, increases after transformation, and that the increase in rate of uptake can account for the observed increase in the rate of glucose accumulation in transformed cells. Furthermore, we conclude that 3-OMeG is transported across the plasma membrane by facilitated diffusion and that the molecular species of the carrier present before and after transformation appear to be the same.
MATERIALS AND METHODS
Cell Growth and Infection. The method of preparation of chick-embryo fibroblasts, the growth of virus stock, and the technique of cell infection have been described (2) . The growth conditions of the cells that were used for the transport experiments have been reported (2) . Under these conditions the rate of growth of normal and RSV-transformed chickembryo fibroblasts was identical, as measured by increase in both cell number and rate of DNA synthesis. DNA synthesis was measured either by [3H]thymidine incorporation into CLCCOOH-insoluble material or by autoradiography (2 1. dissolved in 1 N NaOH and their protein content was determined (12) .
The following difficulties were encountered in measurement of 3-OMeG uptake.
(a) The amount of ['H]3-OMeG taken up by the cells, and particularly by CK(RSV), reaches a plateau very rapidly when measured at 37°. Therefore, to determine the slope of the uptake curve, it is necessary to measure the uptake within a few seconds after addition of the ['H]3-OMeG to the cells and to do the experiment at room temperature, 25°.
(b) The rate of exit of 3-OMeG from RSV-transformed cells is faster than that from uninfected cells (see Fig. 5 ).
Therefore, the loss of [ 
RESULTS

Competition experiments
In order to show that 3-OMeG and glucose use the same carrier to enter the cells, the following criteria must be satisfied: (a) When labeled glucose is used as substrate and either cold 3-OMeG or cold glucose as competitor, 3-OMeG must compete for the entry of labeled glucose to the same extent as does unlabeled glucose, i.e., the 3-OMeG competition for glucose uptake has to be complete. (b) The same must be true when 3-OMeG is used as substrate and glucose as competitor. Any competition experiment that does not satisfy these criteria does not show that glucose and 3-OMeG use the same carrier (13) .
A competition experiment between glucose and 3-OMeG is shown in Fig. 1 for CK(RSV) and in Fig. 2 Additional evidence that 3-OMeG and glucose use the same carrier to enter the cell can be obtained by a chase experiment. In this experiment cells are preloaded with labeled 3-OMeG and then a very high concentration of unlabeled glucose is added to the medium. Thus, glucose is the predominent hexose in the medium, while 3-OMeG predominates intracellularly. If glucose and 3-OMeG use the same carrier(s), this carrier will load glucose on the outside of the plasma membrane, move across the membrane, and release glucose inside the cell. Glucose will be phosphorylated and therefore trapped inside the cell. The carrier, now on the inner side of the membrane, will bind 3-OMeG, and move the analog out of the cell. The net result of this process will be a drop in the concentration of labeled 3-OMeG inside the cell immediately after the addition of glucose in the extracellular space.
The result of this experiment is shown in Fig. 3 . The addition of glucose to the medium of cells preloaded with [3H]3-OMeG causes a sharp drop in the intracellular concentration of the analog. This is confirming evidence that 3-OMeG and glucose use the same carrier(s) to enter the cell.
Kinetics of S-OMeG Uptake. The kinetics of 3-OMeG uptake were studied in fast growing normal and in RSV-transformed cells. To measure the rate of growth of CK and CK (RSV), we labeled the cells with [3H]dT, and the percentage of cells incorporating [3H] dT was determined by autoradiography. Table 1 demonstrates that there were no significant differences in growth rate between the two cell populations. Fig. 4 is a study of 3-OMeG uptake in CK and CK(RSV). CK(RSV) cells transport 3-OMeG at a rate that is about three times faster than that of CK. . The Vmax of the CK(RSV) transport system is 3-fold higher than that of CK (see Table 3 ). The small difference in Km is not reproducible. DISCUSSION Several investigators have used 2-dOG, a glucose analog, to show that the rate of entry of glucose from the medium into the intracellular pool of glucose 6-phosphate (G-6-P) increases after transformation by RNA and DNA tumor viruses (2, 3, 14-16) and growth stimulation of normal cells (17, 18) . The entry of glucose from the medium into the intracellular pool of G-6-P can be influenced by factors such as membrane permeability to glucose, the type of hexokinase(s) present, inhibition of hexokinase by G-6-P, availability of ATP to the hexokinase, and the glucose supply (19) .
Hatanaka et al. (20) measured hexokinase activity in normal and murine sarcoma virus-transformed mouseembryo cells. They found no differences in enzymatic activity between normal and transformed cells. Colby and Edlin (21) have shown that the ATP concentration is identical in CK and CK(RSV). While both 2-dOG and glucose are accumulated at a faster rate in the cells after viral transformation and both are phosphorylated by the hexokinase, Crane and Sols (22) have shown that only G-6-P is a feedback inhibitor of the hexokinase. A decrease of the concentration of glucose in the medium induces an increase of the rate of glucose uptake (24) . They found that in conditions that do not allow for significant depletion of sugar from the medium, polyoma-transformed cells transport hexose at a rate that is three times faster than that of normal cells. These studies indicate that the hexokinase, the ATP concentration, the feedback inhibition of the hexokinase by G-6-P, and the glucose supply are not responsible for the increased rate of glucose accumulation inside the cells after viral transformation. We have further studied glucose permeability in CK and CK(RSV) by using 3-OMeG, a glucose analog that is transported into the cell but is not further metabolized (8) (9) (10) . Although Smith and Gorski (7) have reported that 3-OMeG is not able to compete for the entry of 2-dOG or glucose in rat uterus, we have shown that 3-OMeG and glucose compete with one another in normal and RSV-transformed chick fibroblasts and that the inhibition is complete. This demonstrates that 3-OMeG and glucose use the same carrier(s) to move across the membrane; therefore, the uptake of 3-OMeG can be used as an indicator for the uptake of glucose in CK and CK(RSV). The rate of 3-OMeG (and glucose) transport in chick-embryo fibroblasts increases about 3-fold after transformation by RSV (Fig. 4) . This increase is not dependent upon differences in growth rate between normal and transformed cells (Table 1 ).
This increase in the rate of transport after transformation could be due either to (a) the appearance of a carrier with a higher affinity for glucose, or (b) an increase in either the number of carrier molecules or their mobility. In (a) the Km of the glucose transport system in transformed cells would be lower than that of normal cells, while in (b) the Vmax of the system would increase after transformation, while the Km would remain unchanged. Fig. 6 shows that the Vmax of the glucose carrier increases 3-fold after transformation. The Km is similar in both normal and RSV-transformed cells. This supports the conclusion that the increased rate of glucose transport in CK(RSV) is not due to the appearance of new carrier species, but rather to an increase in either the number or the mobility of the carrier existing in normal cells.
Glucose can enter the cell by two types of catalyzed processes: active transport and facilitated diffusion. Active transport requires energy and is capable of transporting glucose into the cell against a concentration gradient; facilitated diffusion has neither of these characteristics. In animal bodies the active transport of sugar is restricted to the small intestines and the kidneys (25) . The only other tissue that has been found to transport glucose against a concentration gradient is the choroid plexus of dogs (26) . In the small intestines 3-OMeG and glucose are actively transported by a common transport system but 2-dOG is not a substrate for this system (27, 28 , see also ref. 29 ). In erythrocytes, however, which transport sugars by facilitated diffusion, 3-OMeG, glucose, and 2-dOG use the same transport system (30) .
Our studies demonstrated that (a) both normal and RSVtransformed chick-embryo fibroblasts are not able to accumulate glucose against a concentration gradient and (b) both 3-OMeG (Figs. 1 and 2) , and 2-dOG (Venuta, unpublished) use the glucose carrier to enter the cell. Therefore, it can be concluded that chick-embryo fibroblasts, normal and transformed by RSV, transport glucose by facilitated diffusion.
Results similar to those presented in this paper have been obtained independently by Dr. M. Weber.
